Since the early 2000s, an ever-increasing subset of missense pathogenic variants in the <i>ACTG1</i> gene has been associated with an autosomal-dominant, progressive, typically post-lingual non-syndromic hearing loss (NSHL) condition designed as DFNA20/26. Here, ACTG1 is linked to hearing loss disorder.